Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV randomized open-label study of coadministration of 13-valent pneumococcal conjugate vaccine with DTaP and poliovirus vaccines in healthy 2-month-old infants
CTR20232799Phase 4Active
- Sponsor
- Beijing Minhai Biological
- Start
- Sep 2023
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Haemophilus influenzae type b conjugate vaccine in pneumococcal disease, sponsored by Beijing Minhai Biological. Started Sep 2023; status: active.
02
Drugs
Haemophilus influenzae type b conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on CTR20232799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232799.